This New Bill Could Effectively End Compounded GLP-1 Access for Hundreds of Thousands

With the introduction of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025, Congress is revisiting the balance between pharmaceutical manufacturing and compounding. And to be fair, this balance is worth revisiting as the landscape has changed dramatically with the advent of GLP-1 medications. Patients deserve safe medi…